Onychodystrophy
| Onychodystrophy | |
|---|---|
| Term | Onychodystrophy |
| Short definition | Ontruzant - (pronounced) (on-TROO-zant) drug used alone or with other drugs to treat certain types of breast, stomach, and gastroesophageal junction cancer that are HER2 positive. It is also being studied in the treatment of other types of cancer. |
| Type | Cancer terms |
| Specialty | Oncology |
| Language | English |
| Source | NCI |
| Comments | |
Onychodystrophy - (pronounced) (ON-ih-koh-DIS-truh fee) Abnormal changes in the shape, color, texture, and growth of fingernails or toenails. Onychodystrophy is often caused by an infection or injury to the nail. It can also be caused by certain medical conditions, including psoriasis, eczema, warts, cysts, and some tumors. Changes in the nails can also be a sign of chronic heart, lung, liver or kidney disease. Treatment with certain medications, including chemotherapy drugs, can also cause nail changes. Also called nail dystrophy
External links
- Medical encyclopedia article on Onychodystrophy
- Wikipedia's article - Onychodystrophy
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski